SCHEMBL30644644

SCHEMBL30644644

CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.56
▸ LMNA P02545 3/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ THRB P10828 1/20 0.42
▸ LGALS3 P17931 2/20 0.42
▸ POLB P06746 2/20 0.41
▸ NOD2 Q9HC29 1/20 0.41
▸ LGALS8 O00214 1/20 0.39
▸ LGALS4 P56470 1/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CD69 Q07108 2/20 0.39
▸ CA12 O43570 3/20 0.38
▸ CA1 P00915 3/20 0.38
▸ CA2 P00918 3/20 0.38
▸ CA4 P22748 3/20 0.38
▸ CA5A P35218 3/20 0.38
▸ CA7 P43166 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23031946 1.00 MAPK1 (0.56) MAPK1LMNAKMT2AALDH1A1THRB
SCHEMBL18984599 0.90 MAPK1 (0.55) MAPK1LMNAALDH1A1THRBLGALS3
SCHEMBL7888483 0.90 MAPK1 (0.66) MAPK1LMNAALDH1A1THRBLGALS3
SCHEMBL8000037 0.90 MAPK1 (0.66) MAPK1LMNAALDH1A1THRBLGALS3
SCHEMBL7888480 0.90 MAPK1 (0.66) MAPK1LMNAALDH1A1THRBLGALS3
SCHEMBL8000040 0.90 MAPK1 (0.66) MAPK1LMNAALDH1A1THRBLGALS3
SCHEMBL11425414 0.90 MAPK1 (0.66) MAPK1LMNAALDH1A1THRBLGALS3
SCHEMBL5148124 0.85 LMNA (0.57) MAPK1LMNAKMT2AALDH1A1THRB
SCHEMBL19477779 0.85 LMNA (0.57) MAPK1LMNAKMT2AALDH1A1THRB
SCHEMBL20643514 0.85 LMNA (0.57) MAPK1LMNAKMT2AALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3737384-B1 METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING CONDITIONS RELATED TO ALPHA-SYNUCLEIN PUREPHARM INC (CA) 2023-10-25 — — EP disclosed
Send feedback